<?xml version="1.0" encoding="UTF-8"?>
<ref id="B26">
 <label>26.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Ledgerwood</surname>
    <given-names>JE</given-names>
   </name>
   <name>
    <surname>Wei</surname>
    <given-names>CJ</given-names>
   </name>
   <name>
    <surname>Hu</surname>
    <given-names>Z</given-names>
   </name>
   <name>
    <surname>Gordon</surname>
    <given-names>IJ</given-names>
   </name>
   <name>
    <surname>Enama</surname>
    <given-names>ME</given-names>
   </name>
   <name>
    <surname>Hendel</surname>
    <given-names>CS</given-names>
   </name>
   <etal/>
  </person-group>. 
  <article-title>DNA priming and influenza vaccine immunogenicity: two phase 1 open label randomised clinical trials</article-title>. 
  <source>Lancet Infect Dis.</source> (
  <year>2011</year>) 
  <volume>11</volume>:
  <fpage>916</fpage>â€“
  <lpage>24</lpage>. 
  <pub-id pub-id-type="doi">10.1016/S1473-3099(11)70240-7</pub-id>
  <?supplied-pmid 21975270?>
  <pub-id pub-id-type="pmid">21975270</pub-id>
 </mixed-citation>
</ref>
